P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS BY PRIOR LINES OF THERAPY

ABSTRACT:

SUBMITTER: Manier S 

PROVIDER: S-EPMC10431101 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature